26 citations
,
October 2011 in “International Journal of Biological Macromolecules” Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.
136 citations
,
April 2013 in “Clinical Cancer Research” The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.
March 2026 in “Frontiers in Cell and Developmental Biology” Photobiomodulation may help reduce pain and inflammation in knee osteoarthritis, but its long-term benefits are unclear.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Nanocrystals improve drug delivery and bioavailability for poorly soluble drugs.
11 citations
,
October 2001 in “Dermatologic Clinics” The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.
January 2025 in “The Pharma Innovation” Nanospanlastic vesicles can improve glaucoma treatment by enhancing drug delivery to the eye.
September 2025 in “Journal of Polymer Science” Functionalized bacterial cellulose can improve medical tissue engineering.
January 2004 in “Zhongguo xin yao zazhi” The method accurately measures finasteride in plasma, and the test tablets are as effective as the reference ones.
May 2023 in “Elsevier eBooks” Stem cell-based therapies show promise for treating various medical conditions.
August 2024 in “Frontiers in Pharmacology” Antibody treatments show promise for hair loss but need more research.
Choose FDA-cleared red light therapy devices and follow guidelines for safe use.
8 citations
,
July 2024 in “Children” Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.
73 citations
,
September 2016 in “Journal of Translational Medicine” Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.
November 2025 in “Advanced Therapeutics” Platelet-rich plasma can aid tissue repair but faces challenges in standardization.
1 citations
,
January 2022 in “Journal of Pharmaceutical Sciences” The new skin cream with FOL-005 safely promotes hair growth and is stable and user-friendly.
July 2024 in “Open Repository of the University of Porto (University of Porto)” Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.
June 2017 in “DOAJ (DOAJ: Directory of Open Access Journals)” Combining finasteride with dimethyl-β-cyclodextrin improves its absorption and bioavailability.
December 2025 in “Eastern Ukrainian Medical Journal” Standardized protocols are crucial for effective use of platelet-rich plasma and fibrin in tissue regeneration.
December 2022 in “bioRxiv (Cold Spring Harbor Laboratory)” The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.
Bioregulatory medicine improved the dog's health and recovery from chemotherapy side effects.
November 2024 in “Journal of Cosmetic Dermatology” Valproic acid microemulsions improve skin delivery compared to regular solutions.
May 2026 in “Ibero-American Journal of Health Science Research” Regenerative therapies, including platelet-rich plasma (PRP) and stem cells, are revolutionizing dermatology and aesthetic medicine by offering innovative solutions for tissue rejuvenation and repair. PRP, derived from the patient's blood, is rich in growth factors that stimulate cell proliferation and collagen synthesis, promoting effective tissue regeneration. Stem cells, mainly from bone marrow or adipose tissue, can differentiate into various cell types and actively participate in reparative processes. This narrative review highlights the biological foundations, clinical applications, and recent advances of these therapies, emphasizing their safety, efficacy, and transformative potential in aesthetics. It also discusses current limitations and future prospects, stressing the need for more robust clinical studies to standardize protocols and optimize outcomes, ultimately representing a promising approach to personalized, minimally invasive treatments in regenerative dermatology.
1 citations
,
August 2025 in “Molecules” Egg components have potential uses in medicine for healing, drug delivery, and diagnostics.
CD28 is a promising target for treating alopecia areata with belatacept.
CD28 is a promising target for treating alopecia areata with belatacept.
20 citations
,
May 2023 in “Non-coding RNA Research” New delivery systems are improving siRNA treatments for skin conditions.
1 citations
,
May 2025 in “Biomolecules” Synthetic biology can improve sesquiterpenol production by using innovative microbial strategies.
13 citations
,
November 1996 in “International Journal of Dermatology” Liposomes can improve the effectiveness of skin treatments.
November 2025 in “Journal of Medicinal Chemistry” Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.
7 citations
,
July 2022 in “Pharmaceutics” The microneedle device with rapamycin and epigallocatechin gallate effectively promoted hair regrowth in mice.